Patents by Inventor Eva Prieschl

Eva Prieschl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of escin
    Patent number: 9993512
    Abstract: The present invention provides the use of escin for the manufacture of a pharmaceutical preparation for the treatment diseases mediated or caused by activated granulocytes, preferably a type I or type III allergy or septic shock.
    Type: Grant
    Filed: September 30, 2016
    Date of Patent: June 12, 2018
    Assignee: MARINOMED BIOTECHNOLOGIE GMBH
    Inventors: Andreas T. Grassauer, Eva Prieschl
  • USE OF ESCIN
    Publication number: 20170014465
    Abstract: The present invention provides the use of escin for the manufacture of a pharmaceutical preparation for the treatment diseases mediated or caused by activated granulocytes, preferably a type I or type III allergy or septic shock.
    Type: Application
    Filed: September 30, 2016
    Publication date: January 19, 2017
    Inventors: Andreas T. GRASSAUER, Eva PRIESCHL
  • USE OF ESCIN
    Publication number: 20100227830
    Abstract: The present invention provides the use of escin for the manufacture of a pharmaceutical preparation for the treatment diseases mediated or caused by activated granulocytes, preferably a type I or type III allergy or septic shock.
    Type: Application
    Filed: August 3, 2007
    Publication date: September 9, 2010
    Applicant: MARINOMED BIOTECHNOLOGIE GMBH
    Inventors: Andreas Grassauer, Eva Prieschl
  • FcyrIII signaling inhibitor assay
    Publication number: 20050181457
    Abstract: The present invention provides an assay and its use for identifying agents that inhibit the Fc?RIII signaling.
    Type: Application
    Filed: May 16, 2003
    Publication date: August 18, 2005
    Inventors: Thomas Baumruker, Eva Prieschl